Viewing StudyNCT06371040



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06371040
Status: RECRUITING
Last Update Posted: 2024-04-17
First Post: 2024-03-17

Brief Title: Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
Sponsor: Ting Chang MD
Organization: Tang-Du Hospital

Conditions & Keywords Data

Conditions:
Name
Myasthenia Gravis
Keywords:
Name View
Generalized Myasthenia Gravis View
CAR-T Therapy View